Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Adaptive Biotechnologies Corporation    ADPT

ADAPTIVE BIOTECHNOLOGIES CORPORATION

(ADPT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
All news about ADAPTIVE BIOTECHNOLOGIES CORPORATION
01/11ADAPTIVE BIOTECHNOLOGIES : Partners With AstraZeneca to Use ImmunoSEQ T-MAP in O..
MT
01/11Adaptive Biotechnologies to Collaborate with AstraZeneca in Mapping the Immun..
GL
2020Adaptive Biotechnologies to Present at the 39th Annual J.P. Morgan Healthcare..
GL
2020IQVIA-Quest Diagnostics Joint Venture Q2 Form Marketing Partnership With Adap..
MT
2020ADAPTIVE BIOTECHNOLOGIES : Investor Presentation - December 2020
PU
2020Adaptive Biotechnologies Announces New Clinical Data Demonstrating Impact of ..
GL
2020ADAPTIVE BIOTECHNOLOGIES : and Collaborators to Present Data from More Than 35 A..
AQ
2020ADAPTIVE BIOTECHNOLOGIES : and Collaborators to Present Data from More Than 35 A..
AQ
2020Adaptive Biotechnologies and Collaborators to Present Data from More Than 35 ..
GL
2020ADAPTIVE BIOTECHNOLOGIES : Preliminary Data from Real-World Study Demonstrate T-..
AQ
2020Adaptive Biotechnologies Says Data Showed T-Detect Assay Better Identifies Pa..
MT
2020ADAPTIVE BIOTECHNOLOGIES : Preliminary Data from Real-World Study Demonstrate T-..
AQ
2020Preliminary Data from Real-World Study Demonstrate T-cell Testing Outperforms..
GL
2020ADAPTIVE BIOTECHNOLOGIES CORP : Other Events (form 8-K)
AQ
2020BTIG Research Adjusts Adaptive Biotechnologies PT to $63 From $60, Maintains ..
MT
2020SECTOR UPDATE : Late Slump Drags Health Care Stocks Underwater
MT
2020SECTOR UPDATE : Health Care Stocks Hanging On For Narrow Rise
MT
2020Goldman Sachs Adjusts Price Target for Adaptive Biotechnologies to $66 From $..
MT
2020JP Morgan Adjusts Price Target for Adaptive Biotechnologies to $60 From $50, ..
MT
2020Morgan Stanley Adjusts Adaptive Biotechnologies PT to $46 From $42, Maintains..
MT
2020Adaptive Biotechnologies Widens Q3 Loss But Results Surpass Street Views
MT
2020ADAPTIVE BIOTECHNOLOGIES : Management's Discussion and Analysis of Financial Con..
AQ
2020ADAPTIVE BIOTECHNOLOGIES CORP : Results of Operations and Financial Condition, F..
AQ
2020ADAPTIVE BIOTECHNOLOGIES : 3Q Earnings Snapshot
AQ
2020ADAPTIVE BIOTECHNOLOGIES : Announces Collaboration with GSK to Measure Minimal R..
AQ
2020Adaptive Biotechnologies Announces Collaboration with GSK to Measure Minimal ..
GL
2020Earnings Flash (ADPT) ADAPTIVE BIOTECHNOLOGIES Reports Q3 Revenue $26.3M, vs...
MT
2020ADAPTIVE BIOTECHNOLOGIES : Reports Third Quarter 2020 Financial Results
AQ
2020Adaptive Biotechnologies Reports Third Quarter 2020 Financial Results
GL
2020ADAPTIVE BIOTECHNOLOGIES CORPORATION : quaterly earnings release
2020ADAPTIVE BIOTECHNOLOGIES CORP : Change in Directors or Principal Officers (form ..
AQ
2020ADAPTIVE BIOTECHNOLOGIES : to Report Third Quarter Financial Results on November..
AQ
2020ADAPTIVE BIOTECHNOLOGIES : to Report Third Quarter Financial Results on November..
AQ
2020Adaptive Biotechnologies to Report Third Quarter Financial Results on Novembe..
GL
2020Adaptive Biotechnologies to Present at the Morgan Stanley 2020 Healthcare Con..
GL
2020ADAPTIVE BIOTECHNOLOGIES CORP : Other Events, Financial Statements and Exhibits ..
AQ
2020ADAPTIVE BIOTECHNOLOGIES : to Present at the UBS Genomics 2.0 and Medtech Innova..
AQ
2020ADAPTIVE BIOTECHNOLOGIES : 2Q Earnings Snapshot
AQ
2020ADAPTIVE BIOTECHNOLOGIES : Management's Discussion and Analysis of Financial Con..
AQ
2020ADAPTIVE BIOTECHNOLOGIES CORP : Results of Operations and Financial Condition, F..
AQ
2020Adaptive Biotechnologies Reports Second Quarter 2020 Financial Results
GL
2020Adaptive Biotechnologies to Present at the UBS Genomics 2.0 and Medtech Innov..
GL
2020ADAPTIVE BIOTECHNOLOGIES : Receives Expanded FDA Clearance for the clonoSEQ Assa..
AQ
2020ADAPTIVE BIOTECHNOLOGIES : Receives Expanded FDA Clearance for the clonoSEQ® Ass..
AQ
2020ADAPTIVE BIOTECHNOLOGIES CORPORATION : half-yearly earnings release
2020ADAPTIVE BIOTECHNOLOGIES : Launches immunoSEQ T-MAP COVID, First Molecular T Cel..
AQ
2020FOCUS : Next big COVID-19 treatment may be manufactured antibodies
RE
2020Adaptive Biotechnologies Launches National Clinical Trial to Develop Novel T-..
GL
2020ADAPTIVE BIOTECHNOLOGIES CORP : Entry into a Material Definitive Agreement, Resu..
AQ
2020ADAPTIVE BIOTECHNOLOGIES : Announces Pricing of Public Offering of Common Stock
AQ
2020Adaptive Biotechnologies Announces Proposed Public Offering of Common Stock
GL
2020Adaptive Biotechnologies to Report Second Quarter Financial Results on August..
GL
2020How Moderna executives are cashing in on COVID-19 vaccine stock speculation
RE
2020ADAPTIVE BIOTECHNOLOGIES CORP : Change in Directors or Principal Officers (form ..
AQ
2020ADAPTIVE BIOTECHNOLOGIES CORP : Submission of Matters to a Vote of Security Hold..
AQ
2020UPDATE – Adaptive Biotechnologies to Participate in Upcoming June Inves..
GL
2020ADAPTIVE BIOTECHNOLOGIES : to Participate in Upcoming June Investor Conferences
AQ
2020ADAPTIVE BIOTECHNOLOGIES : Management's Discussion and Analysis of Financial Con..
AQ
2020ADAPTIVE BIOTECHNOLOGIES CORP : Results of Operations and Financial Condition, F..
AQ
2020ADAPTIVE BIOTECHNOLOGIES : 1Q Earnings Snapshot
AQ
2020Adaptive Biotechnologies Reports First Quarter 2020 Financial Results
GL
2020Adaptive Biotechnologies to Present at the BofA Securities 2020 Healthcare Co..
GL
2020ADAPTIVE BIOTECHNOLOGIES CORP : Regulation FD Disclosure, Financial Statements a..
AQ
2020Amgen studying Otezla for coronavirus, looking into other treatments
RE
2020Adaptive Biotechnologies to Report First Quarter Financial Results on May 12,..
GL
2020Adaptive Biotechnologies Expands Executive Leadership Team to Support Develop..
GL
2020Adaptive Biotechnologies and Microsoft expand partnership to decode COVID-19 ..
AQ
2020ADAPTIVE BIOTECHNOLOGIES CORP : Regulation FD Disclosure, Financial Statements a..
AQ
2020ADAPTIVE BIOTECHNOLOGIES : 4Q Earnings Snapshot
AQ
2020ADAPTIVE BIOTECHNOLOGIES : Management's Discussion and Analysis of Financial Con..
AQ
2020ADAPTIVE BIOTECHNOLOGIES CORP : Results of Operations and Financial Condition, F..
AQ
2020Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2019 Financial ..
GL
2020Adaptive Biotechnologies to Present at the 40th Annual Cowen Health Care Conf..
GL
2020ADAPTIVE BIOTECHNOLOGIES CORP : Change in Directors or Principal Officers (form ..
AQ
2020Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2019 Financia..
GL
1  2Next
Upcoming event on ADAPTIVE BIOTECHNOLOGIES CORPORATION